The era of ‘trust us’ is over – consumers are demanding proof
For founders building businesses in health and nutrition, the most consequential shift of the past decade is also the quietest. The era of ‘trust us’ is over.
The brands pulling ahead are no longer the ones with the loudest marketing. They are the ones that can answer the question, "How do you know?"
The ones who can demonstrate clinical work on the finished product, not just the raw ingredient. The ones with methodology that holds up and named academic partners – validation that exists outside the company’s own marketing department.
This is uncomfortable for the industry, because it rewards founders who invested in proof when proof was expensive, slow and invisible to consumers – and penalizes everyone else.
I learned how thin ‘proof’ can be the hard way. After a cancer diagnosis in my mid-thirties, I went looking for anything that might support my recovery. Half the people in my life recommended turmeric to reduce inflammation.
Once I knew what to look for, the pattern was everywhere.
It took me weeks to discover that curcumin, its active compound, has almost no oral bioavailability: a standard capsule passes through the body largely unused. That is not contested in the scientific literature. But it did not appear on any label or website within the category.
Once I knew what to look for, the pattern was everywhere. ‘Clinically backed’ usually meant a study of a patented raw ingredient from an overseas supplier, not the finished product in the bottle. Label dosages were often a fraction of what the cited studies had used.
The trade calls this ‘marketing science’. Most of it is legal. Very little of it closes the gap between what the marketing and label implies and what the evidence actually supports. That category has not meaningfully improved in the years since. What is changing radically is the consumer and AI is accelerating the shift.
What changed?
Two shifts converged. The first is that the basic skill of reading scientific evidence – once the preserve of researchers and clinicians – has become broadly available. Anyone with a phone can find peer-reviewed studies, check who funded them and read the limitations. That literacy is uneven, but it is enough that a confident assertion no longer ends an argument – it starts one.
The second is the saturation of AI-generated content. Any brand can now produce infinite polished, plausible marketing copy at zero cost and any influencer can be a synthetic one. Consumers have noticed and the polish itself has become a tell. A December 2025 Clutch survey of consumers found that generic or robotic messaging is now among the fastest trust killers in the market, with more than half citing heavy AI use as an active red flag for inauthenticity.
A survey of consumers found that generic or robotic messaging is now among the fastest trust killers in the market.
The cumulative effect is a consumer who has stopped extending the benefit of the doubt. Trust in commercial messaging and social media ads keeps falling; trust in peer-reviewed evidence and third-party validation keeps rising. In health and wellness, that gap is widening fastest.
"How do you know?" is no longer just a consumer question. Retailers are quietly tightening their evidence requirements for shelf space. Regulators in the United Kingdom, European Union, Australia and the United States are all moving toward stricter substantiation rules.
Journalists who once took nutritional press releases at face value now want the data first. Five years ago that conversation barely happened. Today it is the gating question and a brand that cannot answer it is increasingly locked out of the channels that matter.
What it means for founders
The implication is uncomfortable but, in the end, liberating. It is uncomfortable because the path to a credible brand is now longer and more capital-intensive than it has ever been. You cannot shortcut your way to scientific credibility. You cannot buy it with influencer marketing or manufacture it with a clever brand book.
It is liberating because it finally rewards the founders who were always going to do the work. For most of the past decade those founders carried a structural disadvantage: they spent more, moved slower and watched competitors take share with claims they were not willing to make. That is starting to invert.
Doing the work does not mean every founder needs to build a laboratory, which is complex and expensive. It is more practical than that and it comes down to three moves any brand can make:
Test the product you actually sell. Commission clinical or analytical work on your finished formulation, not the supplier’s data sheet for a raw ingredient. It is the single clearest signal that you are standing behind the thing in the bottle.
Publish the methodology, including the limitations. A claim a skeptical reader can interrogate is worth more than a claim they have to take on faith. Naming what a study did not show builds more trust than another superlative.
Let the evidence change the product. The hardest discipline is acting on what your own testing tells you, even when the finding is inconvenient and the reformulation is expensive.
You cannot shortcut your way to scientific credibility.
A brand that has revised its product in response to its own data has something most competitors never will: proof that the science leads and the marketing follows, not the other way round.
At KURK, we spent seven years building the technology and clinical relationships behind our liquid micellar curcumin solution, including winning two government research grants to work with Swansea Medical School to research the finished product.
For most of that period it would have been faster and cheaper to outsource the science, as most in our category do. We did not, for reasons that were at the time entirely about personal conviction – we are making this formulation for ourselves so need it to work. That the market is now actively selecting in favor of that approach is a welcome surprise.
We did not plan for it; we happened to already be doing it when the tide turned.
The honest counter-argument
It would be naive to claim proof now beats everything. It doesn’t. Distribution, brand and speed still win plenty of contests and a substantiated competitor stuck in the lab can lose two or three years of growth to a louder rival who marketed better.
Proof is slow and capital-intensive and for an early-stage founder choosing where a limited budget goes, that is a real trade-off, not a slogan. The case for proof is not that it wins this quarter. It is that the direction of travel is one-way. Consumer literacy does not regress. Regulators do not loosen substantiation rules. Retailers do not stop asking for evidence.
Over a five-to-10-year horizon, the brands without a credible answer to, "How do you know it works?" will find the cost compounding against them. Proof is a slower play, but it is the more durable one. That is the real lesson and it applies to any founder in a category where trust has eroded, not just health and nutrition.
Proof is no longer a nice-to-have. It is the moat. The brands that own the next decade will be the ones that started building it years before they had to. The era of ‘trust us’ is over. That is good news for consumers, who deserve better – and good news for the founders who were always going to earn it.